By proceeding, you agree to our Terms of Use and Privacy Policy.
KACTUS is a biotechnology company serving global biopharma and diagnostics customers. We focus on commercial protein production for unmet needs in the drug development pipeline, including challenging recombinant proteins such as Claudin 18.2, MHC complexes, GPCR, CD20, and highly bioactive mRNA capping enzymes. Our goal is to deliver first-to-market innovative protein and antibody products. We also offer custom protein production including both research-grade and GMP-grade material.
16-18 May 2023
The 2nd Next Generation RNA Therapeutics Summit is back, and it's the only industry event exclusively dedicated to advancing next generation RNA therapeutics and vaccines. The focus is on developing treatments that are more effective and have fewer o
Event Ended
USA
Paid
Boston
13-15 June 2023
The mRNA Quality Control & Comparability Summit aims to address the lack of knowledge and standardization in the evaluation of mRNA therapeutics and vaccines. The current methods used are difficult to compare and standardize, and there is a need for
13-16 December 2023
The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Deg
Hybrid
San Diego